Properties of Soluble CR2 in Human Serum (Q41612748)

5 October 2017

Properties of soluble CR2 in human serum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1280620

8 September 2022

Properties of Soluble CR2 in Human Serum (English)

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(11)80656-X

21 November 2023

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(11)80656-X

21 November 2023

author name string

N. R. Ling

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1280620

8 September 2022

B. Brown

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1280620

8 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1280620

8 September 2022

publication date

1 August 1992

1 reference

full work available at URL

5 October 2017

https://api.elsevier.com/content/article/PII:S017129851180656X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(11)80656-X

https://api.elsevier.com/content/article/PII:S017129851180656X?httpAccept=text/plain

21 November 2023

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(11)80656-X

21 November 2023

1 reference

5 October 2017

185

1 reference

5 October 2017

2-4

1 reference

5 October 2017

403-414

1 reference

Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment

5 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

Activation of B lymphocytes with human serum-treated zymosan

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980656-X

7 January 2021

Epstein Barr virus/complement C3d receptor is an interferon alpha receptor

series ordinal

4

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(11)80656-X

21 November 2023

Identifiers

0 references

1 reference